Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

NCT01621425 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01621425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01621425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
May 31, 2015
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic castration-resistant prostate carcinoma